Is an early diagnosis of CLL beneficial in its treatment?
Biomarkers for acute myeloid leukemia (AML) – lessons from IL-2 immunotherapy with HDC
Targeted therapies for CLL: new data and unanswered questions
Cytogenetics, TP53 and immunoglobulin genes: exciting areas of research for CLL
How do novel agents affect allogeneic transplantation in CLL?